INVO — INVO Bioscience Cashflow Statement
0.000.00%
Last trade - 00:00- $2.85m
- $5.26m
- $3.02m
Annual cashflow statement for INVO Bioscience, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.17 | -8.35 | -6.65 | -10.9 | -8.03 |
| Depreciation | |||||
| Non-Cash Items | 0.579 | 4.41 | 4.2 | 2.96 | 2.61 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.95 | -0.846 | -3.61 | 1.25 | 0.472 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 1.37 | -4.78 | -6.03 | -6.6 | -4.76 |
| Capital Expenditures | -0.115 | -0.089 | -0.455 | -0.013 | -0.445 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -0.098 | -1.7 | -0.068 | -2.05 |
| Acquisition of Business | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.115 | -0.187 | -2.15 | -0.081 | -2.49 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.229 | 13.8 | 3.77 | 1.09 | 7.39 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.03 | 8.86 | -4.41 | -5.59 | 0.142 |